展览:2015年台湾生技展
Exhibition: 2015 Bio Taiwan Exhibition
阅读中文说明与多语对照DAIWA NEWS & EVENTS
中文为主要阅读文字,英文官方内容作弱显示对照;内容与日本大和官网同步发布翻译。
Exhibition: 2015 Bio Taiwan Exhibition
阅读中文说明与多语对照JDF award to Prof. Egashira (Chiba University), research on rice bran arabinoxylan
阅读中文说明与多语对照Academic Presentation: Food Beyond Science and Technology (Korea)
阅读中文说明与多语对照Training session for Daiwa’s business partners in the Tokyo area
阅读中文说明与多语对照Training session for Daiwa’s business partner in Kansai region
阅读中文说明与多语对照SEKCAMA 20th International Conference of Breast Carcinoma in Slovakia
阅读中文说明与多语对照Daiwa’s business partner in Hungary participated in Integrative Medicine Congress
阅读中文说明与多语对照Exhibition: Health Food Expo, Ingredients and Contract Manufacture 2015
阅读中文说明与多语对照Exhibition: CAM Expo Dusseldorf (Germany)
阅读中文说明与多语对照Academic Presentation: BioBran/MGN-3, arabinoxylan from rice bran, sensitizes breast adenocarcinoma tumor cells to paclitaxel in mice
阅读中文说明与多语对照BioBran Seminar for Indonesian Medical Practitioners
阅读中文说明与多语对照Exhibition: NATURAL PRODUCT EXPO WEST 2015 (DHD USA)
阅读中文说明与多语对照Daiwa’s business partner in Hungary participated in Oncology Symposium
阅读中文说明与多语对照Daiwa’s business partner in Luxembourg organized a conference for onco- gynecologists
阅读中文说明与多语对照Daiwa’s business partner in Czech exhibited at ONCO 2015 in Prague
阅读中文说明与多语对照New Published Research Paper: Effects of Bacillus subtilis var. natto products on symptoms caused by blood flow disturbance in female patients with lifestyle diseases
阅读中文说明与多语对照New Published Research Paper: MGN-3/BioBran enhances generation of cytotoxic CD8+ T cells via upregulation of DEC-205 expression on dendritic cells
阅读中文说明与多语对照New Published Research Paper: Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma, in vitro and in vivo
阅读中文说明与多语对照Exhibition: The Annual World Congress of the American Academy of Anti-aging Medicine 2014 (DHD USA)
阅读中文说明与多语对照Exhibition: The Annual Meeting of Japan Kampo Society
阅读中文说明与多语对照来源:大和药品株式会社日本官网;本站同步核对日期:2026-09-01;版权授权有效期至2030年5月31日。